Review



afp  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems afp
    Afp, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 39 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/af5369/pmc12428306-4-0-2?v=R%26D+Systems
    Average 93 stars, based on 39 article reviews
    afp - by Bioz Stars, 2026-07
    93/100 stars

    Images



    Similar Products

    93
    R&D Systems afp
    Afp, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/af5369/pmc12428306-4-0-2?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    afp - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    93
    R&D Systems mouse afp
    Fig. 1: Intravenously injected iRGD increases blood <t>AFP</t> levels in HCC-bearing mice. (a) Experimental setup to study the effect of iRGD on blood AFP levels in Huh-7 xenografted nude mice. (b and c) Blood AFP levels before and after intravenous injection of iRGD (b, c, n = 12), RGD control peptide (c (n = 6)), and PBS (c (n = 6)) in mice with HepG2 xenografts. Human AFP was not detectable in the blood of mice without tumours. In (c) the fold increase of AFP with pre-injection level set to 1; lines and error bars represent geometric means and 95% CI. (d) Experimental setup to study the effect of iRGD on blood AFP levels in TGFα/c-myc HCC mice. (e and f) iRGD specifically increased the blood AFP levels in TGFα/c-myc HCC mice. TGFα/c-myc mice (20–24 weeks old) with HCC according to MRI or without HCC (f) were intravenously injected with iRGD (e, f), RGD control peptide (f) or PBS (f). Data are fold changes of blood AFP due to the treatments (n = 48: iRGD; RGD control peptide: n = 34; PBS: n = 15); lines and error bars indicate medians and 95% CI. Dashed line: upper 95% CI increase in blood AFP in the PBS-injected HCC mice. (g) AFP expression in HCCs of TGFα/c-myc mice. HCCs and liver tissues were excised from TGFα/c-myc mice. Pairs of the tissue lysates were analysed for AFP <t>and</t> <t>β-actin</t> content by immunoblotting. Band densities were measured densitometrically. The ratio of AFP/β-actin in the livers was set to 1. (h) iRGD-induced accumulation of Evans blue in HCCs in TGFα/c-myc mice with HCC. TGFα/c-myc mice with HCCs were co- injected with iRGD or PBS (n = 12 per group) and Evans blue (EB). The dye content of the tumours was related to that in the livers; lines and error bars indicate geometric means (b, c, and h) or medians (e and f) and 95% CI; dashed line: upper 95% CI of the measured EB content of a HCC from the PBS-injected animals. (b): paired t test for log-transformed data; (c) One-way ANOVA with multiple comparison post-hoc test for log-transformed data; (e): Wilcoxon signed-rank test for log-transformed data; (f) Kruskal–Wallis test with Dunn’s multiple comparison post- hoc test; (h): two-sample t test. The indicated fold increase in (b, e and h) is the ratio of the geometric means with 95% CI.
    Mouse Afp, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/af5369/pm38889481-76-32-34?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    mouse afp - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    93
    R&D Systems nitrocellulose membranes
    Fig. 1: Intravenously injected iRGD increases blood <t>AFP</t> levels in HCC-bearing mice. (a) Experimental setup to study the effect of iRGD on blood AFP levels in Huh-7 xenografted nude mice. (b and c) Blood AFP levels before and after intravenous injection of iRGD (b, c, n = 12), RGD control peptide (c (n = 6)), and PBS (c (n = 6)) in mice with HepG2 xenografts. Human AFP was not detectable in the blood of mice without tumours. In (c) the fold increase of AFP with pre-injection level set to 1; lines and error bars represent geometric means and 95% CI. (d) Experimental setup to study the effect of iRGD on blood AFP levels in TGFα/c-myc HCC mice. (e and f) iRGD specifically increased the blood AFP levels in TGFα/c-myc HCC mice. TGFα/c-myc mice (20–24 weeks old) with HCC according to MRI or without HCC (f) were intravenously injected with iRGD (e, f), RGD control peptide (f) or PBS (f). Data are fold changes of blood AFP due to the treatments (n = 48: iRGD; RGD control peptide: n = 34; PBS: n = 15); lines and error bars indicate medians and 95% CI. Dashed line: upper 95% CI increase in blood AFP in the PBS-injected HCC mice. (g) AFP expression in HCCs of TGFα/c-myc mice. HCCs and liver tissues were excised from TGFα/c-myc mice. Pairs of the tissue lysates were analysed for AFP <t>and</t> <t>β-actin</t> content by immunoblotting. Band densities were measured densitometrically. The ratio of AFP/β-actin in the livers was set to 1. (h) iRGD-induced accumulation of Evans blue in HCCs in TGFα/c-myc mice with HCC. TGFα/c-myc mice with HCCs were co- injected with iRGD or PBS (n = 12 per group) and Evans blue (EB). The dye content of the tumours was related to that in the livers; lines and error bars indicate geometric means (b, c, and h) or medians (e and f) and 95% CI; dashed line: upper 95% CI of the measured EB content of a HCC from the PBS-injected animals. (b): paired t test for log-transformed data; (c) One-way ANOVA with multiple comparison post-hoc test for log-transformed data; (e): Wilcoxon signed-rank test for log-transformed data; (f) Kruskal–Wallis test with Dunn’s multiple comparison post- hoc test; (h): two-sample t test. The indicated fold increase in (b, e and h) is the ratio of the geometric means with 95% CI.
    Nitrocellulose Membranes, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/af5369/pm38889481-76-24-34?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    nitrocellulose membranes - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    93
    R&D Systems alpha fetoprotein goat r d systems af5369
    Fig. 1: Intravenously injected iRGD increases blood <t>AFP</t> levels in HCC-bearing mice. (a) Experimental setup to study the effect of iRGD on blood AFP levels in Huh-7 xenografted nude mice. (b and c) Blood AFP levels before and after intravenous injection of iRGD (b, c, n = 12), RGD control peptide (c (n = 6)), and PBS (c (n = 6)) in mice with HepG2 xenografts. Human AFP was not detectable in the blood of mice without tumours. In (c) the fold increase of AFP with pre-injection level set to 1; lines and error bars represent geometric means and 95% CI. (d) Experimental setup to study the effect of iRGD on blood AFP levels in TGFα/c-myc HCC mice. (e and f) iRGD specifically increased the blood AFP levels in TGFα/c-myc HCC mice. TGFα/c-myc mice (20–24 weeks old) with HCC according to MRI or without HCC (f) were intravenously injected with iRGD (e, f), RGD control peptide (f) or PBS (f). Data are fold changes of blood AFP due to the treatments (n = 48: iRGD; RGD control peptide: n = 34; PBS: n = 15); lines and error bars indicate medians and 95% CI. Dashed line: upper 95% CI increase in blood AFP in the PBS-injected HCC mice. (g) AFP expression in HCCs of TGFα/c-myc mice. HCCs and liver tissues were excised from TGFα/c-myc mice. Pairs of the tissue lysates were analysed for AFP <t>and</t> <t>β-actin</t> content by immunoblotting. Band densities were measured densitometrically. The ratio of AFP/β-actin in the livers was set to 1. (h) iRGD-induced accumulation of Evans blue in HCCs in TGFα/c-myc mice with HCC. TGFα/c-myc mice with HCCs were co- injected with iRGD or PBS (n = 12 per group) and Evans blue (EB). The dye content of the tumours was related to that in the livers; lines and error bars indicate geometric means (b, c, and h) or medians (e and f) and 95% CI; dashed line: upper 95% CI of the measured EB content of a HCC from the PBS-injected animals. (b): paired t test for log-transformed data; (c) One-way ANOVA with multiple comparison post-hoc test for log-transformed data; (e): Wilcoxon signed-rank test for log-transformed data; (f) Kruskal–Wallis test with Dunn’s multiple comparison post- hoc test; (h): two-sample t test. The indicated fold increase in (b, e and h) is the ratio of the geometric means with 95% CI.
    Alpha Fetoprotein Goat R D Systems Af5369, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/af5369/pmc10722291__DataSheet_1-21-13-15?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    alpha fetoprotein goat r d systems af5369 - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    94
    R&D Systems alpha fetoprotein
    Fig. 1: Intravenously injected iRGD increases blood <t>AFP</t> levels in HCC-bearing mice. (a) Experimental setup to study the effect of iRGD on blood AFP levels in Huh-7 xenografted nude mice. (b and c) Blood AFP levels before and after intravenous injection of iRGD (b, c, n = 12), RGD control peptide (c (n = 6)), and PBS (c (n = 6)) in mice with HepG2 xenografts. Human AFP was not detectable in the blood of mice without tumours. In (c) the fold increase of AFP with pre-injection level set to 1; lines and error bars represent geometric means and 95% CI. (d) Experimental setup to study the effect of iRGD on blood AFP levels in TGFα/c-myc HCC mice. (e and f) iRGD specifically increased the blood AFP levels in TGFα/c-myc HCC mice. TGFα/c-myc mice (20–24 weeks old) with HCC according to MRI or without HCC (f) were intravenously injected with iRGD (e, f), RGD control peptide (f) or PBS (f). Data are fold changes of blood AFP due to the treatments (n = 48: iRGD; RGD control peptide: n = 34; PBS: n = 15); lines and error bars indicate medians and 95% CI. Dashed line: upper 95% CI increase in blood AFP in the PBS-injected HCC mice. (g) AFP expression in HCCs of TGFα/c-myc mice. HCCs and liver tissues were excised from TGFα/c-myc mice. Pairs of the tissue lysates were analysed for AFP <t>and</t> <t>β-actin</t> content by immunoblotting. Band densities were measured densitometrically. The ratio of AFP/β-actin in the livers was set to 1. (h) iRGD-induced accumulation of Evans blue in HCCs in TGFα/c-myc mice with HCC. TGFα/c-myc mice with HCCs were co- injected with iRGD or PBS (n = 12 per group) and Evans blue (EB). The dye content of the tumours was related to that in the livers; lines and error bars indicate geometric means (b, c, and h) or medians (e and f) and 95% CI; dashed line: upper 95% CI of the measured EB content of a HCC from the PBS-injected animals. (b): paired t test for log-transformed data; (c) One-way ANOVA with multiple comparison post-hoc test for log-transformed data; (e): Wilcoxon signed-rank test for log-transformed data; (f) Kruskal–Wallis test with Dunn’s multiple comparison post- hoc test; (h): two-sample t test. The indicated fold increase in (b, e and h) is the ratio of the geometric means with 95% CI.
    Alpha Fetoprotein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/af5369/us11814650-390-64-66?v=R%26D+Systems
    Average 94 stars, based on 1 article reviews
    alpha fetoprotein - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    94
    R&D Systems goat igg
    Fig. 1: Intravenously injected iRGD increases blood <t>AFP</t> levels in HCC-bearing mice. (a) Experimental setup to study the effect of iRGD on blood AFP levels in Huh-7 xenografted nude mice. (b and c) Blood AFP levels before and after intravenous injection of iRGD (b, c, n = 12), RGD control peptide (c (n = 6)), and PBS (c (n = 6)) in mice with HepG2 xenografts. Human AFP was not detectable in the blood of mice without tumours. In (c) the fold increase of AFP with pre-injection level set to 1; lines and error bars represent geometric means and 95% CI. (d) Experimental setup to study the effect of iRGD on blood AFP levels in TGFα/c-myc HCC mice. (e and f) iRGD specifically increased the blood AFP levels in TGFα/c-myc HCC mice. TGFα/c-myc mice (20–24 weeks old) with HCC according to MRI or without HCC (f) were intravenously injected with iRGD (e, f), RGD control peptide (f) or PBS (f). Data are fold changes of blood AFP due to the treatments (n = 48: iRGD; RGD control peptide: n = 34; PBS: n = 15); lines and error bars indicate medians and 95% CI. Dashed line: upper 95% CI increase in blood AFP in the PBS-injected HCC mice. (g) AFP expression in HCCs of TGFα/c-myc mice. HCCs and liver tissues were excised from TGFα/c-myc mice. Pairs of the tissue lysates were analysed for AFP <t>and</t> <t>β-actin</t> content by immunoblotting. Band densities were measured densitometrically. The ratio of AFP/β-actin in the livers was set to 1. (h) iRGD-induced accumulation of Evans blue in HCCs in TGFα/c-myc mice with HCC. TGFα/c-myc mice with HCCs were co- injected with iRGD or PBS (n = 12 per group) and Evans blue (EB). The dye content of the tumours was related to that in the livers; lines and error bars indicate geometric means (b, c, and h) or medians (e and f) and 95% CI; dashed line: upper 95% CI of the measured EB content of a HCC from the PBS-injected animals. (b): paired t test for log-transformed data; (c) One-way ANOVA with multiple comparison post-hoc test for log-transformed data; (e): Wilcoxon signed-rank test for log-transformed data; (f) Kruskal–Wallis test with Dunn’s multiple comparison post- hoc test; (h): two-sample t test. The indicated fold increase in (b, e and h) is the ratio of the geometric means with 95% CI.
    Goat Igg, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/af5369/pm37798118-227-14-16?v=R%26D+Systems
    Average 94 stars, based on 1 article reviews
    goat igg - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    94
    R&D Systems af5369
    Fig. 1: Intravenously injected iRGD increases blood <t>AFP</t> levels in HCC-bearing mice. (a) Experimental setup to study the effect of iRGD on blood AFP levels in Huh-7 xenografted nude mice. (b and c) Blood AFP levels before and after intravenous injection of iRGD (b, c, n = 12), RGD control peptide (c (n = 6)), and PBS (c (n = 6)) in mice with HepG2 xenografts. Human AFP was not detectable in the blood of mice without tumours. In (c) the fold increase of AFP with pre-injection level set to 1; lines and error bars represent geometric means and 95% CI. (d) Experimental setup to study the effect of iRGD on blood AFP levels in TGFα/c-myc HCC mice. (e and f) iRGD specifically increased the blood AFP levels in TGFα/c-myc HCC mice. TGFα/c-myc mice (20–24 weeks old) with HCC according to MRI or without HCC (f) were intravenously injected with iRGD (e, f), RGD control peptide (f) or PBS (f). Data are fold changes of blood AFP due to the treatments (n = 48: iRGD; RGD control peptide: n = 34; PBS: n = 15); lines and error bars indicate medians and 95% CI. Dashed line: upper 95% CI increase in blood AFP in the PBS-injected HCC mice. (g) AFP expression in HCCs of TGFα/c-myc mice. HCCs and liver tissues were excised from TGFα/c-myc mice. Pairs of the tissue lysates were analysed for AFP <t>and</t> <t>β-actin</t> content by immunoblotting. Band densities were measured densitometrically. The ratio of AFP/β-actin in the livers was set to 1. (h) iRGD-induced accumulation of Evans blue in HCCs in TGFα/c-myc mice with HCC. TGFα/c-myc mice with HCCs were co- injected with iRGD or PBS (n = 12 per group) and Evans blue (EB). The dye content of the tumours was related to that in the livers; lines and error bars indicate geometric means (b, c, and h) or medians (e and f) and 95% CI; dashed line: upper 95% CI of the measured EB content of a HCC from the PBS-injected animals. (b): paired t test for log-transformed data; (c) One-way ANOVA with multiple comparison post-hoc test for log-transformed data; (e): Wilcoxon signed-rank test for log-transformed data; (f) Kruskal–Wallis test with Dunn’s multiple comparison post- hoc test; (h): two-sample t test. The indicated fold increase in (b, e and h) is the ratio of the geometric means with 95% CI.
    Af5369, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/af5369/pm37798118-227-18-16?v=R%26D+Systems
    Average 94 stars, based on 1 article reviews
    af5369 - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    93
    R&D Systems r d systems af5369
    Fig. 1: Intravenously injected iRGD increases blood <t>AFP</t> levels in HCC-bearing mice. (a) Experimental setup to study the effect of iRGD on blood AFP levels in Huh-7 xenografted nude mice. (b and c) Blood AFP levels before and after intravenous injection of iRGD (b, c, n = 12), RGD control peptide (c (n = 6)), and PBS (c (n = 6)) in mice with HepG2 xenografts. Human AFP was not detectable in the blood of mice without tumours. In (c) the fold increase of AFP with pre-injection level set to 1; lines and error bars represent geometric means and 95% CI. (d) Experimental setup to study the effect of iRGD on blood AFP levels in TGFα/c-myc HCC mice. (e and f) iRGD specifically increased the blood AFP levels in TGFα/c-myc HCC mice. TGFα/c-myc mice (20–24 weeks old) with HCC according to MRI or without HCC (f) were intravenously injected with iRGD (e, f), RGD control peptide (f) or PBS (f). Data are fold changes of blood AFP due to the treatments (n = 48: iRGD; RGD control peptide: n = 34; PBS: n = 15); lines and error bars indicate medians and 95% CI. Dashed line: upper 95% CI increase in blood AFP in the PBS-injected HCC mice. (g) AFP expression in HCCs of TGFα/c-myc mice. HCCs and liver tissues were excised from TGFα/c-myc mice. Pairs of the tissue lysates were analysed for AFP <t>and</t> <t>β-actin</t> content by immunoblotting. Band densities were measured densitometrically. The ratio of AFP/β-actin in the livers was set to 1. (h) iRGD-induced accumulation of Evans blue in HCCs in TGFα/c-myc mice with HCC. TGFα/c-myc mice with HCCs were co- injected with iRGD or PBS (n = 12 per group) and Evans blue (EB). The dye content of the tumours was related to that in the livers; lines and error bars indicate geometric means (b, c, and h) or medians (e and f) and 95% CI; dashed line: upper 95% CI of the measured EB content of a HCC from the PBS-injected animals. (b): paired t test for log-transformed data; (c) One-way ANOVA with multiple comparison post-hoc test for log-transformed data; (e): Wilcoxon signed-rank test for log-transformed data; (f) Kruskal–Wallis test with Dunn’s multiple comparison post- hoc test; (h): two-sample t test. The indicated fold increase in (b, e and h) is the ratio of the geometric means with 95% CI.
    R D Systems Af5369, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/af5369/pm37798118-227-16-16?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    r d systems af5369 - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    Image Search Results


    Fig. 1: Intravenously injected iRGD increases blood AFP levels in HCC-bearing mice. (a) Experimental setup to study the effect of iRGD on blood AFP levels in Huh-7 xenografted nude mice. (b and c) Blood AFP levels before and after intravenous injection of iRGD (b, c, n = 12), RGD control peptide (c (n = 6)), and PBS (c (n = 6)) in mice with HepG2 xenografts. Human AFP was not detectable in the blood of mice without tumours. In (c) the fold increase of AFP with pre-injection level set to 1; lines and error bars represent geometric means and 95% CI. (d) Experimental setup to study the effect of iRGD on blood AFP levels in TGFα/c-myc HCC mice. (e and f) iRGD specifically increased the blood AFP levels in TGFα/c-myc HCC mice. TGFα/c-myc mice (20–24 weeks old) with HCC according to MRI or without HCC (f) were intravenously injected with iRGD (e, f), RGD control peptide (f) or PBS (f). Data are fold changes of blood AFP due to the treatments (n = 48: iRGD; RGD control peptide: n = 34; PBS: n = 15); lines and error bars indicate medians and 95% CI. Dashed line: upper 95% CI increase in blood AFP in the PBS-injected HCC mice. (g) AFP expression in HCCs of TGFα/c-myc mice. HCCs and liver tissues were excised from TGFα/c-myc mice. Pairs of the tissue lysates were analysed for AFP and β-actin content by immunoblotting. Band densities were measured densitometrically. The ratio of AFP/β-actin in the livers was set to 1. (h) iRGD-induced accumulation of Evans blue in HCCs in TGFα/c-myc mice with HCC. TGFα/c-myc mice with HCCs were co- injected with iRGD or PBS (n = 12 per group) and Evans blue (EB). The dye content of the tumours was related to that in the livers; lines and error bars indicate geometric means (b, c, and h) or medians (e and f) and 95% CI; dashed line: upper 95% CI of the measured EB content of a HCC from the PBS-injected animals. (b): paired t test for log-transformed data; (c) One-way ANOVA with multiple comparison post-hoc test for log-transformed data; (e): Wilcoxon signed-rank test for log-transformed data; (f) Kruskal–Wallis test with Dunn’s multiple comparison post- hoc test; (h): two-sample t test. The indicated fold increase in (b, e and h) is the ratio of the geometric means with 95% CI.

    Journal: EBioMedicine

    Article Title: Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice.

    doi: 10.1016/j.ebiom.2024.105178

    Figure Lengend Snippet: Fig. 1: Intravenously injected iRGD increases blood AFP levels in HCC-bearing mice. (a) Experimental setup to study the effect of iRGD on blood AFP levels in Huh-7 xenografted nude mice. (b and c) Blood AFP levels before and after intravenous injection of iRGD (b, c, n = 12), RGD control peptide (c (n = 6)), and PBS (c (n = 6)) in mice with HepG2 xenografts. Human AFP was not detectable in the blood of mice without tumours. In (c) the fold increase of AFP with pre-injection level set to 1; lines and error bars represent geometric means and 95% CI. (d) Experimental setup to study the effect of iRGD on blood AFP levels in TGFα/c-myc HCC mice. (e and f) iRGD specifically increased the blood AFP levels in TGFα/c-myc HCC mice. TGFα/c-myc mice (20–24 weeks old) with HCC according to MRI or without HCC (f) were intravenously injected with iRGD (e, f), RGD control peptide (f) or PBS (f). Data are fold changes of blood AFP due to the treatments (n = 48: iRGD; RGD control peptide: n = 34; PBS: n = 15); lines and error bars indicate medians and 95% CI. Dashed line: upper 95% CI increase in blood AFP in the PBS-injected HCC mice. (g) AFP expression in HCCs of TGFα/c-myc mice. HCCs and liver tissues were excised from TGFα/c-myc mice. Pairs of the tissue lysates were analysed for AFP and β-actin content by immunoblotting. Band densities were measured densitometrically. The ratio of AFP/β-actin in the livers was set to 1. (h) iRGD-induced accumulation of Evans blue in HCCs in TGFα/c-myc mice with HCC. TGFα/c-myc mice with HCCs were co- injected with iRGD or PBS (n = 12 per group) and Evans blue (EB). The dye content of the tumours was related to that in the livers; lines and error bars indicate geometric means (b, c, and h) or medians (e and f) and 95% CI; dashed line: upper 95% CI of the measured EB content of a HCC from the PBS-injected animals. (b): paired t test for log-transformed data; (c) One-way ANOVA with multiple comparison post-hoc test for log-transformed data; (e): Wilcoxon signed-rank test for log-transformed data; (f) Kruskal–Wallis test with Dunn’s multiple comparison post- hoc test; (h): two-sample t test. The indicated fold increase in (b, e and h) is the ratio of the geometric means with 95% CI.

    Article Snippet: Immunoblotting of lysates obtained from pairs of liver and HCC tissue from TGFα/c-myc mice was performed as described previously.38 Gel-resolved proteins were electrotransferred to nitrocellulose membranes and incubated with antibodies raised against mouse-AFP (#AF5369, R&D Systems, Minneapolis, MN, RRID:AB_2258018) and anti-β-actin (#A2066, Sigma– Aldrich/Merck, RRID:AB_476693).

    Techniques: Injection, Control, Expressing, Western Blot, Transformation Assay, Comparison

    Fig. 3: iRGD-induced elevation of the blood AFP concentration depends on NRP-1 and the tumour blood concentration gradient of AFP. (a) Anti-NRP-1 prevented iRGD-induced increase in the blood AFP concentration. TGFα/c-myc tumour mice that displayed a robust iRGD-induced increase in blood AFP level one week earlier were injected with anti-NRP-1 and the effect of iRGD on blood AFP level was determined (n = 3 per group). Fold increase of AFP with pre-injection level at the first time point was set to 1. Lines and error bars represent medians and 95% CI. (b– e) iRGD-induced elevation of the blood AFP level correlated negatively with the pre-injection blood AFP level in TGFα/c-myc mice (b), DEN- CCl4-HCC mice (c), mice with Huh-7 (d) or HepG2 xenografts (e). Spearman correlation r (b and c) and Pearson correlation r (d and e) with 95% CI, two tailed p-values and the log–log regression lines. (f) iRGD increased the blood AFP levels in HepG2 xenografted nude mice and low basal AFP (<67 ng/ml, n = 36, left panel), but not in animals with high basal AFP (>67 ng/ml, n = 12, right panel). Lines and error bars indicate geometric means and 95% CI. [(g) iRGD increased the blood AFP levels in TGFα/c-myc mice with HCC and normal basal AFP (<67 ng/ml, n = 36, left panel), but not in mice with elevated basal AFP (>67 ng, n = 12, right panel). Lines and error bars represent medians (left) or geometric means (right) with 95% CI. Significance was calculated with one sample t test (a, left) and the unpaired t test (a, right), paired t test (f and g, right) and Wilcoxon matched-pairs signed-rank test (g, left). The indicated fold increase in (f) is the geometric mean ratio with 95% CI. The indicated fold increase in (g) is the median of the ratios with 95% CI.

    Journal: EBioMedicine

    Article Title: Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice.

    doi: 10.1016/j.ebiom.2024.105178

    Figure Lengend Snippet: Fig. 3: iRGD-induced elevation of the blood AFP concentration depends on NRP-1 and the tumour blood concentration gradient of AFP. (a) Anti-NRP-1 prevented iRGD-induced increase in the blood AFP concentration. TGFα/c-myc tumour mice that displayed a robust iRGD-induced increase in blood AFP level one week earlier were injected with anti-NRP-1 and the effect of iRGD on blood AFP level was determined (n = 3 per group). Fold increase of AFP with pre-injection level at the first time point was set to 1. Lines and error bars represent medians and 95% CI. (b– e) iRGD-induced elevation of the blood AFP level correlated negatively with the pre-injection blood AFP level in TGFα/c-myc mice (b), DEN- CCl4-HCC mice (c), mice with Huh-7 (d) or HepG2 xenografts (e). Spearman correlation r (b and c) and Pearson correlation r (d and e) with 95% CI, two tailed p-values and the log–log regression lines. (f) iRGD increased the blood AFP levels in HepG2 xenografted nude mice and low basal AFP (<67 ng/ml, n = 36, left panel), but not in animals with high basal AFP (>67 ng/ml, n = 12, right panel). Lines and error bars indicate geometric means and 95% CI. [(g) iRGD increased the blood AFP levels in TGFα/c-myc mice with HCC and normal basal AFP (<67 ng/ml, n = 36, left panel), but not in mice with elevated basal AFP (>67 ng, n = 12, right panel). Lines and error bars represent medians (left) or geometric means (right) with 95% CI. Significance was calculated with one sample t test (a, left) and the unpaired t test (a, right), paired t test (f and g, right) and Wilcoxon matched-pairs signed-rank test (g, left). The indicated fold increase in (f) is the geometric mean ratio with 95% CI. The indicated fold increase in (g) is the median of the ratios with 95% CI.

    Article Snippet: Immunoblotting of lysates obtained from pairs of liver and HCC tissue from TGFα/c-myc mice was performed as described previously.38 Gel-resolved proteins were electrotransferred to nitrocellulose membranes and incubated with antibodies raised against mouse-AFP (#AF5369, R&D Systems, Minneapolis, MN, RRID:AB_2258018) and anti-β-actin (#A2066, Sigma– Aldrich/Merck, RRID:AB_476693).

    Techniques: Concentration Assay, Injection, Two Tailed Test